Nanogel Particles Based on Modified Nucleosides and Oligosaccharides as Advanced Delivery System

ACS Nano. 2023 Nov 28;17(22):23020-23031. doi: 10.1021/acsnano.3c08627. Epub 2023 Nov 7.

Abstract

This work addresses the challenge of delivering bioactive molecules by designing biocompatible nanogel particles (NGPs) utilizing rationally modified nature-sourced building blocks: capryl-oligochitosan and oxidized inosine. Capryl substituents endowed the resultant NGPs with membrane-penetration capabilities, while purine-containing inosine allowed H-bond/π-π/π-cation interactions. The prepared NGPs were complexed with carboxyfluorescein-labeled single-stranded oligonucleotide (FAM-oligo) and DsRed-encoding plasmid DNA. The successful delivery of FAM-oligo to the cell cytoplasm of the Nicotiana benthamiana plant was observed. Alexa 555-labeled bovine serum albumin (Alexa 555-BSA) was also efficiently encapsulated and delivered to the plant. In addition to delivering FAM-oligo and Alexa 555-BSA separately, NGPs also successfully co-delivered both biomolecules to the plant. Finally, NGPs successfully encapsulated the drug amphotericin B and reduced its toxicity while maintaining its efficacy. The presented findings suggest that NGPs may become a promising platform for the advanced delivery of bioactive molecules in various applications.

Keywords: co-delivery; drug delivery; gene delivery; inosine dialdehyde; nanogel particles; oligochitosan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Delivery Systems
  • Inosine
  • Nanogels
  • Nucleosides*
  • Oligosaccharides*
  • Serum Albumin, Bovine

Substances

  • polyethylene glycol polyethyleneimine nanogel
  • Nanogels
  • Nucleosides
  • Oligosaccharides
  • Inosine
  • Serum Albumin, Bovine